ARTiST: Aromasin® Randomised TrIal +/- Sutent® as neoadjuvant Therapy for post-menopausal women with breast cancer

Trial Profile

ARTiST: Aromasin® Randomised TrIal +/- Sutent® as neoadjuvant Therapy for post-menopausal women with breast cancer

Completed
Phase of Trial: Phase II

Latest Information Update: 09 Sep 2015

At a glance

  • Drugs Exemestane; Sunitinib
  • Indications Advanced breast cancer
  • Focus Therapeutic Use
  • Acronyms ARTiST
  • Most Recent Events

    • 10 Jun 2017 Biomarkers information updated
    • 04 Mar 2011 Status changed from recruiting to completed as reported by ISRCTN: Current Controlled Trials.
    • 11 Mar 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top